Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa

Launched by SWISS TROPICAL & PUBLIC HEALTH INSTITUTE · May 19, 2023

Keywords

ClinConnect Summary

**Clinical Trial Summary: Chronic Kidney Disease in Sub-Saharan Africa**

This clinical trial is investigating chronic kidney disease (CKD) and its related health risks in Sub-Saharan Africa. CKD is a serious condition that can lead to heart problems and is becoming more common in this region. The study aims to gather better information about how often CKD occurs, what causes it, and how it affects people's health over time. Researchers will look at a group of 1,200 adults from a local hospital and community clinics to understand the key factors that contribute to CKD, including well-known risks like high blood pressure and diabetes, as well as other factors that haven’t been studied as much, such as infections and lifestyle habits.

To participate, individuals must be at least 18 years old, live in the area served by the Bagamoyo district hospital, and be of African descent. Participants will undergo various health checks and tests throughout the year to help track changes in kidney health and related risks. This important research will help improve our understanding of CKD in this part of the world, potentially leading to better prevention and treatment strategies in the future. If you're interested in participating, please consider the eligibility criteria and be prepared for follow-up visits during the study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • all adult patients (≥18 years) attending the outpatients department of the Bagamoyo district hospital (BDH) or the associated Fukayosi and Yombo dispensary
• Exclusion Criteria:
• • \<18 years of age
• • not living in the BDH catchment area
• • not of African decent
• • not willing to come back for follow-up visits